Behind the Study: Potential Therapeutic Target in Breast Cancer Cells
May 17, 2021
Dr. John Hawse from the Mayo Clinic in Minnesota, U.S., discusses his 2017 study published by Oncotarget, entitled, "ERβ inhibits cyclin dependent kinases 1 and 7 in triple negative breast cancer." continue reading »